Our prior transcriptomic profiling, filtering, validation, and mechanistic studies identified HOXA4 and SPRR1A as major direct targets of protective actions mediated by miR-150 in ischemic adult mouse hearts and primary human CFs [17,18]. The gene discussed is HOXA4; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.